Impact of Iron Overload in Pediatric Patients Undergoing Stem Cell Transplantation
N/A
5 Years
N/A
5 Years
N/A
Not Enrolling
Both
Iron Overload
Both
Iron Overload
Trial Information
Impact of Iron Overload in Pediatric Patients Undergoing Stem Cell Transplantation
Inclusion Criteria
1. Undergoing allogeneic HSCT for malignant or non-malignant conditions
2. Age greater than or equal to 5 years
3. Able to undergo MRI without a need for general anesthesia
4. No metal implants
5. Signed informed consent (by parent if patient is less than 18 years old, or by
patient, if he or she is greater than 18 years old).
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Hepatic iron content as measured by R2 MRI.
Outcome Time Frame:
Pre-HSCT and Day 100
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
DFCI 07-004
NCT ID:
NCT00806715
Start Date:
February 2007
Completion Date:
October 2010
Related Keywords:
- Iron Overload
- hemochromatosis
- Iron overload
- Stem cell transplant
- Pediatrics
- Pediatric Stem cell transplant
- Iron Overload
Name | Location |
|---|---|
| Children's Hospital Boston | Boston, Massachusetts 02115 |
